Express Scripts Holding (ESRX) Receives Consensus Rating of “Hold” from Brokerages
Shares of Express Scripts Holding (NASDAQ:ESRX) have received a consensus recommendation of “Hold” from the twenty-six analysts that are currently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation, nine have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $79.66.
A number of brokerages have issued reports on ESRX. BidaskClub cut Express Scripts from a “buy” rating to a “hold” rating in a report on Wednesday. Royal Bank of Canada raised Express Scripts from a “sector perform” rating to an “outperform” rating and set a $68.00 price objective for the company in a report on Wednesday, January 31st. Robert W. Baird lifted their price objective on Express Scripts from $57.00 to $59.00 and gave the company a “neutral” rating in a report on Wednesday, October 25th. SunTrust Banks reissued a “buy” rating and set a $95.00 price objective on shares of Express Scripts in a report on Friday, January 12th. Finally, Mizuho set a $86.00 price objective on Express Scripts and gave the company a “hold” rating in a report on Wednesday, January 24th.
Shares of Express Scripts (ESRX) traded up $0.70 during midday trading on Wednesday, hitting $73.59. The company’s stock had a trading volume of 3,720,900 shares, compared to its average volume of 4,276,801. The company has a market capitalization of $41,282.93, a PE ratio of 12.12, a PEG ratio of 0.78 and a beta of 0.93. Express Scripts has a 12 month low of $55.80 and a 12 month high of $83.49. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73.
In other news, VP Christine Houston sold 10,104 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $70.08, for a total value of $708,088.32. Following the completion of the sale, the vice president now directly owns 87,400 shares in the company, valued at $6,124,992. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Glen D. Stettin sold 3,449 shares of the firm’s stock in a transaction on Thursday, January 11th. The shares were sold at an average price of $81.00, for a total value of $279,369.00. Following the completion of the sale, the vice president now owns 33,715 shares of the company’s stock, valued at $2,730,915. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,001 shares of company stock valued at $1,249,505. 0.68% of the stock is currently owned by corporate insiders.
Several large investors have recently made changes to their positions in the company. Ameriprise Financial Inc. increased its position in Express Scripts by 23.5% in the third quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock worth $331,374,000 after purchasing an additional 996,816 shares during the period. Arrowstreet Capital Limited Partnership increased its position in Express Scripts by 31.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 3,450,844 shares of the company’s stock worth $257,571,000 after purchasing an additional 835,464 shares during the period. Pzena Investment Management LLC increased its position in Express Scripts by 23.6% in the third quarter. Pzena Investment Management LLC now owns 3,509,800 shares of the company’s stock worth $222,241,000 after purchasing an additional 670,922 shares during the period. Bank of New York Mellon Corp increased its position in Express Scripts by 8.7% in the fourth quarter. Bank of New York Mellon Corp now owns 8,287,905 shares of the company’s stock worth $618,609,000 after purchasing an additional 666,754 shares during the period. Finally, Schwab Charles Investment Management Inc. increased its position in Express Scripts by 21.1% in the third quarter. Schwab Charles Investment Management Inc. now owns 3,700,527 shares of the company’s stock worth $234,318,000 after purchasing an additional 644,208 shares during the period. Institutional investors own 87.46% of the company’s stock.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.